Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention - PubMed (original) (raw)

doi: 10.1111/apt.12466. Epub 2013 Aug 27.

Affiliations

PMID: 23981126
DOI: 10.1111/apt.12466

Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention

S S Pattni et al. Aliment Pharmacol Ther. 2013 Oct.

Abstract

Background: Bile acid diarrhoea is a common, under-diagnosed cause of chronic watery diarrhoea, responding to specific treatment with bile acid sequestrants. We previously showed patients with bile acid diarrhoea have lower median levels compared with healthy controls, of the ileal hormone fibroblast growth factor 19 (FGF19), which regulates bile acid synthesis.

Aim: To measure serum FGF19 and SeHCAT retention prospectively in patients with chronic diarrhoea.

Methods: One hundred and fifty-two consecutive patients were grouped according to (75) Se-homocholic acid taurine (SeHCAT) 7-day retention: normal (>15%) in 72 (47%) diarrhoea controls; ≤15% in 54 (36%) with primary bile acid diarrhoea, and in 26 (17%) with secondary bile acid diarrhoea. Fasting blood was assayed for FGF19, 7α-hydroxy-4-cholesten-3-one (C4) and total bile acids.

Results: FGF19 was significantly lower in the primary bile acid diarrhoea group compared with the diarrhoea control group (median 147 vs. 225 pg/mL, P < 0.001), and also in the secondary group (P < 0.006). FGF19 and SeHCAT values were positively correlated (rs = 0.44, P < 0.001); both were inversely related to C4. Other significant relationships included SeHCAT and body mass index (BMI)(P = 0.02), and FGF19 with age (P < 0.01). The negative and positive predictive values of FGF19 ≤ 145 pg/mL for a SeHCAT <10% were 82% and 61%, respectively, and were generally improved in an index including BMI, age and C4. In a subset of 28 primary patients, limited data suggested that FGF19 could predict response to sequestrant therapy.

Conclusions: Reduced fibroblast growth factor 19 is a feature of bile acid diarrhoea. Further studies will fully define its role in predicting the response of these patients to therapy.

PubMed Disclaimer

Comment in

Commentary: fibroblast growth factor 19 in patients with bile acid diarrhoea.
Camilleri M, Acosta A. Camilleri M, et al. Aliment Pharmacol Ther. 2013 Nov;38(10):1320-1. doi: 10.1111/apt.12487. Aliment Pharmacol Ther. 2013. PMID: 24134500 Free PMC article. No abstract available.

Cited by

Association between weight-adjusted-waist index and bowel habits.
Yang X, Sun Z. Yang X, et al. Sci Rep. 2024 Jul 26;14(1):17658. doi: 10.1038/s41598-024-66869-2. Sci Rep. 2024. PMID: 39085333 Free PMC article.
Demographic and Dietary Associations of Chronic Diarrhea in a Representative Sample of Adults in the United States.
Singh P, Mitsuhashi S, Ballou S, Rangan V, Sommers T, Cheng V, Iturrino-Moreda J, Friedlander D, Nee J, Lembo A. Singh P, et al. Am J Gastroenterol. 2018 Apr;113(4):593-600. doi: 10.1038/ajg.2018.24. Epub 2018 Mar 6. Am J Gastroenterol. 2018. PMID: 29610515
Mechanisms of triglyceride metabolism in patients with bile acid diarrhea.
Sagar NM, McFarlane M, Nwokolo C, Bardhan KD, Arasaradnam RP. Sagar NM, et al. World J Gastroenterol. 2016 Aug 14;22(30):6757-63. doi: 10.3748/wjg.v22.i30.6757. World J Gastroenterol. 2016. PMID: 27570415 Free PMC article.
Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis.
Di Vincenzo F, Puca P, Lopetuso LR, Petito V, Masi L, Bartocci B, Murgiano M, De Felice M, Petronio L, Gasbarrini A, Scaldaferri F. Di Vincenzo F, et al. Nutrients. 2022 Jun 27;14(13):2664. doi: 10.3390/nu14132664. Nutrients. 2022. PMID: 35807844 Free PMC article. Review.
The Farnesoid X Receptor: Good for BAD.
Keely SJ, Walters JR. Keely SJ, et al. Cell Mol Gastroenterol Hepatol. 2016 Aug 29;2(6):725-732. doi: 10.1016/j.jcmgh.2016.08.004. eCollection 2016 Nov. Cell Mol Gastroenterol Hepatol. 2016. PMID: 28174746 Free PMC article. Review.

Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention - PubMed (original) (raw)